Study on the occurrence and development of miR-153-3p/miR-222 in gastric cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000039861

Enrollment

Unknown

Registered

2020-11-12

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

Gastric cancer group:Nil

Early gastric cancer group:Nil

Health control group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Age: 18-70 years old; (2) Patients with gastric cancer or early gastric cancer who were diagnosed by surgery or endoscopic pathology; (3) Normal volunteers matched by gender and age; (4) Informed and voluntary participation in the study and signing of informed consent;

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) With other active malignant tumors, cerebral stroke, myocardial infarction and other serious primary diseases; (3) Patients with a history of gastrointestinal tumors other than gastric cancer and a history of abdominal surgery; (4) Patients with a history of mental illness.

Design outcomes

Primary

Measure	Time frame
miR153/222 in tissues;miR153/222 in serum;	—

Countries

China

Contacts

Public ContactTian Li

Weihai Municipal Hospital

litian_55@163.com+86 13563103602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026